MedTrace Logo

Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy

NCT02790242 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1089

Last updated 2023-04-13

No results posted yet for this study

Summary

The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from heart transplant or ventricular assist device. This will allow to offer the state-of-the-art care to the patients in heart failure.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Hiroo Takayama, MD, PhD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2020-02-11
Completion
2020-02-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02790242 on ClinicalTrials.gov